Business Description
Harvard Apparatus Regenerative Technology Inc
NAICS : 325412
SIC : 2834
ISIN : US09074M2026
Description
Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.92 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -10.95 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7 | |||||
| 3-Year EPS without NRI Growth Rate | -6.7 | |||||
| 3-Year FCF Growth Rate | -3.9 | |||||
| 3-Year Book Growth Rate | -0.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.01 | |||||
| 9-Day RSI | 53.43 | |||||
| 14-Day RSI | 49.91 | |||||
| 12-1 Month Momentum % | -44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.19 | |||||
| Quick Ratio | 3.1 | |||||
| Cash Ratio | 2.88 | |||||
| Days Inventory | 222.44 | |||||
| Days Sales Outstanding | 5.82 | |||||
| Days Payable | 2078.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | -14.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.89 | |||||
| Operating Margin % | -3484.68 | |||||
| Net Margin % | -3495.32 | |||||
| FCF Margin % | -2104.26 | |||||
| ROE % | -507.85 | |||||
| ROA % | -259.08 | |||||
| ROIC % | -422.59 | |||||
| ROC (Joel Greenblatt) % | -6159.09 | |||||
| ROCE % | -486.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 175.88 | |||||
| PB Ratio | 12.41 | |||||
| Price-to-Tangible-Book | 12.46 | |||||
| EV-to-EBIT | -4.98 | |||||
| EV-to-EBITDA | -5.11 | |||||
| EV-to-Revenue | 172.4 | |||||
| EV-to-FCF | -8.19 | |||||
| Price-to-Net-Current-Asset-Value | 18.69 | |||||
| Price-to-Net-Cash | 23 | |||||
| Earnings Yield (Greenblatt) % | -20.08 | |||||
| FCF Yield % | -10.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HRGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harvard Apparatus Regenerative Technology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.235 | ||
| EPS (TTM) ($) | -0.58 | ||
| Beta | -0.75 | ||
| Volatility % | 111.66 | ||
| 14-Day RSI | 49.91 | ||
| 14-Day ATR ($) | 0.128352 | ||
| 20-Day SMA ($) | 2.87693 | ||
| 12-1 Month Momentum % | -44 | ||
| 52-Week Range ($) | 2.13 - 5.9 | ||
| Shares Outstanding (Mil) | 15.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harvard Apparatus Regenerative Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harvard Apparatus Regenerative Technology Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harvard Apparatus Regenerative Technology Inc Frequently Asked Questions
What is Harvard Apparatus Regenerative Technology Inc(HRGN)'s stock price today?
The current price of HRGN is $2.99. The 52 week high of HRGN is $5.90 and 52 week low is $2.13.
When is next earnings date of Harvard Apparatus Regenerative Technology Inc(HRGN)?
The next earnings date of Harvard Apparatus Regenerative Technology Inc(HRGN) is 2025-02-28 Est..
Does Harvard Apparatus Regenerative Technology Inc(HRGN) pay dividends? If so, how much?
Harvard Apparatus Regenerative Technology Inc(HRGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers